Evidence map›Paper›PMID 3039354›Full record

ArticleMolecular and cellular biology1987

Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells.

J B Trepel, O R Colamonici, K Kelly, G Schwab, R A Watt, E A Sausville, E S Jaffe, L M Neckers

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1987. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP.Proceedings of the National Academy of Sciences of the United States of America · 1994
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Two genetic loci participate in the regulation by iron of the gene for the human transferrin receptor.Proceedings of the National Academy of Sciences of the United States of America · 1988
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

J B Trepel
O R Colamonici
K Kelly
G Schwab
R A Watt
E A Sausville
E S Jaffe
L M Neckers
National Cancer Institute · MYNational Cancer Institute · UAUpsher-Smith Laboratories (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of HL-60 cells with dibutyryl cyclic AMP induced rapid transcriptional inactivation of c-myc and the transferrin receptor. Transcriptional inactivation was followed by loss of c-myc and transferrin receptor mRNA and protein. Treated cells completed one round of proliferation, followed by growth arrest, G1 synchronization, and monocytic differentiation. These data suggest that cyclic AMP-mediated control of growth and differentiation may be achieved, at least in part, by transcriptional regulation of certain growth-associated proto-oncogenes and growth factor receptor genes.

Indexed as

BucladesineCell DifferentiationCell DivisionCell LineHumansLeukemia, Myeloid, AcuteProto-Oncogene ProteinsProto-Oncogene Proteins c-mycProto-OncogenesReceptors, TransferrinTranscription, GeneticBucladesineProto-Oncogene ProteinsProto-Oncogene Proteins c-mycReceptors, Transferrin

Identifiers

PMID3039354
PMCPMC365406
OpenAlexW1962723822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.